New drug improves outcome in treatment resistant kidney cancer

28 septiembre 2015

A new drug for renal cell carcinoma slowed the growth of advanced kidney cancer in patients who became resistant to the first-line therapies that had previously kept it in check, according to results from a clinical trial.